Interview Times 
In the realm of healthcare, where science and technology converge for the betterment of humanity, inDNA Life Sciences Private Limited stands as a beacon of innovation and hope. Founded in 2013 with a vision to bring affordable and accessible DNA-based diagnostics to the Indian population, inDNA has emerged as a leader in personalized healthcare. Let’s embark on a journey through the corridors of inDNA, unraveling its commitment to excellence, the pioneering spirit of its founder, Dr. Birendranath Banerjee, and the transformative impact it envisions for the future.
At the core of inDNA’s philosophy is the belief that our DNA holds the key to personalized healthcare solutions. Through comprehensive genetic tests, inDNA empowers individuals with insights into their predisposition to diseases, medication responses, and overall health profiles. This transformative information enables informed decision-making, facilitating preventive measures and targeted treatment strategies. The company’s commitment to harnessing the power of DNA has positioned it as a pioneer in the evolving landscape of personalized medicine.
From early cancer detection and risk assessment to identifying genetic disorders in children, inDNA’s portfolio is designed to provide a holistic view of an individual’s health. Molecular Fertility tests offer couples valuable insights into reproductive health, while Wellness tests assess genetic predispositions to various health conditions. This comprehensive approach underscores inDNA’s commitment to offering solutions across the healthcare spectrum.
In the nucleus of inDNA’s success story stands Dr. Birendranath Banerjee, a renowned molecular biologist with over two decades of experience in genetics. His journey, from a master’s student in human genetics to the founder and managing director of inDNA, reflects a deep commitment to advancing healthcare in India. Dr. Banerjee’s passion for molecular diagnostics and the desire to contribute to the well-being of the Indian population have been the driving forces behind inDNA’s transformative impact.
The inception of inDNA was not without its challenges. Dr. Banerjee, upon returning to Bhubaneswar, faced the dual challenge of introducing a novel concept – DNA testing – and addressing the affordability concerns associated with it. The lack of awareness and the presence of certain taboos surrounding DNA testing posed hurdles. However, through dedication and a commitment to accessibility, inDNA successfully overcame these challenges, establishing itself as a trusted name in genetic diagnostics.
In a groundbreaking initiative to revolutionize cancer care, inDNA Life Sciences Private Limited will spearheading molecular tests for cancer patients on a Public-Private Partnership (PPP) Mode. This means that the tests, which play a pivotal role in understanding tumor biology for precise treatment planning, are provided free of cost to patients, with the state government shouldering the financial responsibility.
Selected through a rigorous open tender process by the Odisha State Medical Corporation Limited (OSMCL), inDNA Laboratory has partnered with prestigious institutions like Acharya Harihara Post Graduate Institute for Cancer (AHPGIC), SCB Medical College, and other tertiary care centers. The collaboration ensures that samples are collected from these esteemed institutions, processed in the specialized laboratory in Bhubaneswar, and the comprehensive reports are submitted back to the respective healthcare centers.
This initiative, funded entirely by the State Government through the Nidan Scheme, aims to extend the benefits of advanced molecular tests to cancer patients. Recognizing the significance of these tests in guiding targeted therapies, the Health & Family Welfare department plans to implement this program across various institutions, including SCB Cuttack, MKCG Berhampur, VIMSAR Burla, PRMMCH Baripada, FMMCH Balasore, BBMCH in Balangir, SLNMCH Koraput, Capital Hospital Bhubaneswar, and RGH Rourkela. inDNA Life Sciences is at the forefront of this transformative healthcare initiative, ensuring that precision medicine becomes an accessible reality for all.
In the dynamic landscape of healthcare, inDNA stands as a testament to the transformative potential of genetic diagnostics. Driven by a vision of personalized healthcare for all, inDNA continues to break barriers, overcome challenges, and pave the way for a future where our DNA becomes the compass guiding us towards healthier, more informed lives. With every test conducted, inDNA is advancing healthcare, one DNA insight at a time, and ushering in a new era of well-being for the Indian populace.
As we look ahead, inDNA envisions a future where personalized healthcare is not a luxury but a norm. The company aims to expand its offerings, making comprehensive genetic information accessible to all. With a growing network of collection centers and a commitment to affordability, inDNA is poised to play a pivotal role in shaping a healthier future for the Indian population.
